Global Prevalence Of Depression In Chronic Kidney Disease: A Systematic Review And Meta-Analysis
Oluseyi Ademola Adejumo,Imuetinyan Rahsida Edeki,Oyedepo Dapo,Joshua Falade,Olawale Elijah Yisau,Olanrewaju Olumide Ige,Adedayo Oluwadamilola Adesida,Hansel Palencia,Ayman Moussa,Jibril Abdulmalik,Jean Jacques Noubiap,Udeme Ekpenyong Ekrikpo,Adejumo,O. A.,Edeki,I. R.,Dapo,O.,Falade,J.,Yisau,O. E.,Ige,O. O.,Adesida,A. O.,Palencia,H.,Moussa,A. S.,Abdulmalik,J.,Noubiap,J. J.,Ekrikpo,U. E.
DOI: https://doi.org/10.1101/2023.09.03.23294994
2023-09-05
MedRxiv
Abstract:Chronic kidney disease, CKD, is commonly associated with psychosocial problems, especially depression, contributing to poor overall outcomes in CKD patients. Depression has not been given adequate priority in the management of CKD despite its significant adverse impact. This systematic review and meta-analysis determined the pooled prevalence of clinical depression in the global CKD population and sub-populations. A systematic search of PubMed, AJOL, and EMBASE was undertaken to identify published articles with relevant data between 1989 and 2022. The pooled prevalence of clinical depression in the global CKD population was determined using random effects meta-analytic techniques. Eligible Sixty-one articles were included in this review, comprising 79,691 CKD patients from 26 countries. The mean age ranged from 11.0 to 76.3 years. Most (68.9%) of the studies had medium methodological quality. The overall pooled prevalence of depression was 27.6% (95% CI: 23.9 to 31.5%). Studies using Diagnostic Statistical Manual (DSM), International Classification of Disease, Mini-International Neuropsychiatric Interview and Structured Clinical Interview for DSM disorder returned a pooled prevalence of 31.7%, 39.6%, 23.3%, 25.1%, respectively; p=0.09. There was a significant difference in the pooled prevalence of CKD across the various continents; p=0.01.The prevalence of depression was higher among patients on chronic haemodialysis compared to those in pre-dialysis (31.1% versus 18.9%; p=0.02) and among those on hemodialysis compared to peritoneal dialysis (31.9% versus 20.4%; p=0.03). There was no significant difference between adults and children (28.0% versus 15.9%, p=0.17). Conclusion: Depression is a common disorder in patients with CKD. The findings of this study have brought to the fore the need for clinicians to make deliberate efforts to evaluate CKD patients for depression, especially those with advanced stages of the disease. The study protocol was registered with PROSPERO, CRD42022382708.